Description

6-Nitroindazole (CAS No. 7597-18-4) is a high-purity nitro-substituted indazole derivative with the molecular formula C₇H₅N₃O₂. This compound is widely utilized in pharmaceutical research, organic synthesis, and biochemical applications due to its versatile reactivity as an intermediate. With a molecular weight of 163.14 g/mol, it appears as a fine yellow to beige crystalline powder, offering excellent solubility in organic solvents such as DMSO and ethanol while exhibiting limited solubility in water. Our product is rigorously tested to ensure ≥97% purity (HPLC), making it ideal for precise laboratory use, including enzyme inhibition studies, medicinal chemistry, and heterocyclic compound development. Packaged under inert conditions to ensure stability, each batch includes comprehensive analytical documentation (COA, MSDS) for traceability and compliance with industry standards.

Properties

• CAS Number: 7597-18-4
• Complexity: 192
• IUPAC Name: 6-nitro-1H-indazole
• InChI: InChI=1S/C7H5N3O2/c11-10(12)6-2-1-5-4-8-9-7(5)3-6/h1-4H,(H,8,9)
• InChI Key: ORZRMRUXSPNQQL-UHFFFAOYSA-N
• Exact Mass: 163.038176411
• Molecular Formula: C7H5N3O2
• Molecular Weight: 163.13
• SMILES: C1=CC2=C(C=C1[N+](=O)[O-])NN=C2
• Topological: 74.5
• Monoisotopic Mass: 163.038176411
• Solubility: >24.5 [ug/mL]
• Synonyms: 6-Nitroindazole, 6-Nitro-1H-indazole, 6-Nitro-2H-indazole, 1H-INDAZOLE, 6-NITRO-, 6-Nitroisoindazole, CCRIS 3263, 6-nitro-indazole, EINECS 231-500-9, NSC 35066, NSC 56816, BRN 0007812, DTXSID40884407, 5-23-06-00183 (Beilstein Handbook Reference), DTXCID901023848, 231-500-9, inchi=1/c7h5n3o2/c11-10(12)6-2-1-5-4-8-9-7(5)3-6/h1-4h,(h,8,9, orzrmruxspnqql-uhfffaoysa-n, 7597-18-4, 65750-02-9, 2H-Indazole, 6-nitro-, MFCD00005695, CHEMBL54277, MLS000069593, SMR000059016, 6NI, 6-nitro-indazol, Tocris-0710, Opera_ID_909, 6-Nitroindazole, 97%, MLS001148387, SCHEMBL271522, SCHEMBL406467, SCHEMBL406468, SCHEMBL15066491, HMS2233A08, HMS3371G13, BCP27055, CS-M3172, NSC35066, NSC56816, AC-650, BDBM50284964, MFCD18814731, NSC-35066, NSC-56816, SBB002530, STK772159, AKOS000121370, BS-3879, DB03100, PB17036, SDCCGSBI-0661348.P001, NCGC00024743-01, PD059858, SY003000, DB-050618, ST4083964, N0399, NS00045990, EN300-16639, F18039, A838566, AQ-776/42801160, SR-01000597626, SR-01000597626-1, Q27456476, Z56347246, F0001-1920

6-Nitroindazole serves as a key precursor in synthesizing bioactive compounds, particularly as an inhibitor of neuronal nitric oxide synthase (nNOS) in neuropharmacology research. It is employed in the development of antitumor and antimicrobial agents due to its heterocyclic scaffold. Researchers also utilize it in PET radioligand synthesis for imaging studies. Its nitro group facilitates further functionalization in medicinal chemistry workflows.

Safety and Hazards

GHS Hazard Statements

• H302 (91.3%): Harmful if swallowed [Warning Acute toxicity, oral]
• H312 (89.1%): Harmful in contact with skin [Warning Acute toxicity, dermal]
• H315 (97.8%): Causes skin irritation [Warning Skin corrosion/irritation]
• H319 (97.8%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
• H332 (89.1%): Harmful if inhaled [Warning Acute toxicity, inhalation]
• H335 (95.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
• H351 (89.1%): Suspected of causing cancer [Warning Carcinogenicity]

Precautionary Statements

• P203, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501

Hazard Classes and Categories

• Acute Tox. 4 (91.3%)
• Acute Tox. 4 (89.1%)
• Skin Irrit. 2 (97.8%)
• Eye Irrit. 2A (97.8%)
• Acute Tox. 4 (89.1%)
• STOT SE 3 (95.7%)
• Carc. 2 (89.1%)

If you are interested or have any questions, please contact us at support@atomfair.com

Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.